- Home
- ISOU vs CYRX Comparison
ISOU vs CYRX Comparison
Compare ISOU & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ISOU | CYRX |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | Canada | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 680.3M | 814.9M |
| IPO Year | 2025 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ISOU | CYRX |
|---|---|---|
| Price | $9.07 | $17.20 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 8 |
| Target Price | N/A | ★ $13.31 |
| AVG Volume (30 Days) | 135.4K | ★ 451.2K |
| Earning Date | 05-26-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.19 | $7.61 |
| 52 Week High | $13.58 | $17.98 |
Technical Indicators
Market Signals| Indicator | ISOU | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 35.91 | 60.29 |
| Support Level | $7.80 | $14.55 |
| Resistance Level | $12.19 | N/A |
| Average True Range (ATR) | 0.54 | 0.56 |
| MACD | -0.18 | 0.08 |
| Stochastic Oscillator | 3.38 | 76.11 |
Price Performance
Historical ComparisonAbout ISOU IsoEnergy Ltd.
IsoEnergy Ltd is engaged in the acquisition, exploration, and evaluation of uranium properties in Canada. The company's project profile includes Geiger, Thorburn Lake, Full Moon, Edge, Collins Bay Extension, North Thorburn, 2Z Lake, and Madison. It operates in Canada, the United States, and Australia.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.